Author

Adrienne Sallets

Stanford Cancer InstituteORCID 0000-0002-3333-7609Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:multiome· 1

Frequent Co-Authors

Ole Audun Werner HaabethiD· 2 shared Anushtha SharmaiD· 1 shared Chris S. RaeiD· 1 shared Colin J. McKinlayiD· 1 shared Daniel J. FernandeziD· 1 shared Daniel O. FrimannssoniD· 1 shared Debra Katherine CzerwinskiiD· 1 shared Diane M Da Silva· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Ole Audun Werner HaabethORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vivo mRNA delivery to the lung vascular endothelium by dicationic Charge-Altering Releasable Transporters

Mahmoud M. Abd Elwakil, J. Ni, Summer Ramsay-Burrough, Paul Joshua Hurst, Rebecca Lane McClellan, Samuel R. Khasnavis, Yuan Jia, Sehar R. Masud, Timothy R. Blake, Adrienne Sallets, Ole Audun Werner Haabeth, Idit Sagiv-Barfi, Debra Katherine Czerwinski, Marco Herrera‐Barrera, Ronald Levy, , Robert M. Waymouth

This study develops dicationic Charge-Altering Releasable Transporters (CARTs) that deliver mRNA specifically to lung endothelial cells via intravenous administration.

Journal of the American Chemical Society · Oct 21, 2025Peer-reviewedBioengineering

NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability.

Meredith L.L. Leong, Weiqun Liu, Nicole C. Fay, Diane M Da Silva, Li Ou, Chris S. Rae, Adrienne Sallets, Ruben Prins, Daniel O. Frimannsson, Colin J. McKinlay, Ray Lieh Yoon Low, Daniel J. Fernandez, Gunasekaran Kannan, Pragyesh Dhungel, Sangeeta Nath, , Ole Audun Werner Haabeth

This paper introduces NTX250, an mRNA-based immunotherapy platform for HPV-associated cancers that induces tumor regression and durable immune memory in preclinical models.

bioRxiv · Sep 24, 2025 · PreprintImmunology